Polaryx Therapeutics, Inc.
PLYX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002075320
No open-market purchases or sales by Polaryx Therapeutics, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $5.83M in total; no superinvestor holds it.
Superinvestors holding PLYX, Q2 2026
No superinvestor reported holding PLYX in Q2 2026.